105 related articles for article (PubMed ID: 38941818)
1. Integrated bioinformatics and multiomics reveal Liupao tea extract alleviating NAFLD via regulating hepatic lipid metabolism and gut microbiota.
Yang S; Wei Z; Luo J; Wang X; Chen G; Guan X; She Z; Liu W; Tong Y; Liu H; Wen M; Chen H; Zhu P; Li G; Wang D; Huang L; Xu S; Chen D; Zhang Q; Wei Y
Phytomedicine; 2024 Jun; 132():155834. PubMed ID: 38941818
[TBL] [Abstract][Full Text] [Related]
2. Combining bioinformatics and multiomics strategies to investigate the key microbiota and active components of Liupao tea ameliorating hyperlipidemia.
Zhou H; Wang X; She Z; Huang L; Wei H; Yang S; Wei Z; Chen H; Yang B; Hu Z; Feng X; Zhu P; Li Z; Shen J; Liu H; Dong H; Chen G; Zhang Q
J Ethnopharmacol; 2024 Jun; 333():118438. PubMed ID: 38848972
[TBL] [Abstract][Full Text] [Related]
3. Shenling Baizhu powder alleviates non-alcoholic fatty liver disease by modulating autophagy and energy metabolism in high-fat diet-induced rats.
Pan M; Deng Y; Qiu Y; Pi D; Zheng C; Liang Z; Zhen J; Fan W; Song Q; Pan J; Li Y; Yan H; Yang Q; Zhang Y
Phytomedicine; 2024 Jul; 130():155712. PubMed ID: 38763008
[TBL] [Abstract][Full Text] [Related]
4. Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses.
Wang S; Li X; Zhang B; Li Y; Chen K; Qi H; Gao M; Rong J; Liu L; Wan Y; Dong X; Yan M; Ma L; Li P; Zhao T
Biomed Pharmacother; 2024 Apr; 173():116405. PubMed ID: 38484559
[TBL] [Abstract][Full Text] [Related]
5. Theabrownin inhibits obesity and non-alcoholic fatty liver disease in mice via serotonin-related signaling pathways and gut-liver axis.
Li HY; Huang SY; Zhou DD; Xiong RG; Luo M; Saimaiti A; Han MK; Gan RY; Zhu HL; Li HB
J Adv Res; 2023 Oct; 52():59-72. PubMed ID: 36639024
[TBL] [Abstract][Full Text] [Related]
6. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
[TBL] [Abstract][Full Text] [Related]
7. Integrating metabolomics, 16S rRNA sequencing, network pharmacology, and metorigin to explore the mechanism of Cinnamomi Cortex in treating chronic atrophic gastritis rats.
Liu Y; Zhang H; Lu W; Jiang T
Phytomedicine; 2023 Dec; 121():155084. PubMed ID: 37722245
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice.
Xie F; Xu HF; Zhang J; Liu XN; Kou BX; Cai MY; Wu J; Dong JL; Meng QH; Wang Y; Chen D; Zhang Y
Front Immunol; 2022; 13():974872. PubMed ID: 36466835
[TBL] [Abstract][Full Text] [Related]
9. Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy.
Qiu J; Chen L; Zhang L; Xu F; Zhang C; Ren G; Chang K; He G; Du Z; Le Y; Yu Z; Li S; Liu Q; Dou X
Phytomedicine; 2023 Dec; 121():155111. PubMed ID: 37804819
[TBL] [Abstract][Full Text] [Related]
10. Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation.
Liu G; Yang L; Tang Y; Lin J; Wang F; Shen J; Chang B; Kong X
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117330. PubMed ID: 37863399
[TBL] [Abstract][Full Text] [Related]
11. Smilax China L. polysaccharide prevents HFD induced-NAFLD by regulating hepatic fat metabolism and gut microbiota.
Zhang W; Yu L; Yang Q; Zhang J; Wang W; Hu X; Li J; Zheng G
Phytomedicine; 2024 May; 127():155478. PubMed ID: 38452696
[TBL] [Abstract][Full Text] [Related]
12. Integrative multi-omics unravels the amelioration effects of Zanthoxylum bungeanum Maxim. on non-alcoholic fatty liver disease.
Huang X; Yuan Z; Liu X; Wang Z; Lu J; Wu L; Lin X; Zhang Y; Pi W; Cai D; Chu F; Wang P; Lei H
Phytomedicine; 2023 Jan; 109():154576. PubMed ID: 36610127
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of Xiaoyao San in treating non-alcoholic fatty liver disease with liver depression and spleen deficiency: based on bioinformatics, metabolomics and
Ruan X; Zhang X; Liu L; Zhang J
J Biomol Struct Dyn; 2024 Jul; 42(10):5128-5146. PubMed ID: 37440274
[TBL] [Abstract][Full Text] [Related]
15.
Huang Y; Cao J; Zhu M; Wang Z; Jin Z; Xiong Z
Microbiol Spectr; 2024 Apr; 12(4):e0339323. PubMed ID: 38411057
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of Ginkgo biloba in treating type 2 diabetes mellitus combined with non-alcoholic fatty liver disease based on network pharmacology, molecular docking, and experimental evaluations.
Xu S; Tang L; Qian X; Wang Y; Gong J; Yang H; Su D
J Food Biochem; 2022 Dec; 46(12):e14419. PubMed ID: 36121703
[TBL] [Abstract][Full Text] [Related]
17. Anti-NAFLD effect of defatted walnut powder extract in high fat diet-induced C57BL/6 mice by modulating the gut microbiota.
Ren SM; Zhang QZ; Chen ML; Jiang M; Zhou Y; Xu XJ; Wang DM; Pan YN; Liu XQ
J Ethnopharmacol; 2021 Apr; 270():113814. PubMed ID: 33444725
[TBL] [Abstract][Full Text] [Related]
18. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
[TBL] [Abstract][Full Text] [Related]
19. Integrated network pharmacology, metabolomics, and transcriptomics of Huanglian-Hongqu herb pair in non-alcoholic fatty liver disease.
Zhang X; Zhang J; Zhou Z; Xiong P; Cheng L; Ma J; Wen Y; Shen T; He X; Wang L; Zhang Y; Xiao C
J Ethnopharmacol; 2024 May; 325():117828. PubMed ID: 38325669
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg
Shi Y; Chen J; Qu D; Sun Q; Yu Y; Zhang H; Liu Z; Sha J; Sun Y
Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]